ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Indiana » Rheumatology

Top Rheumatology Prescribers in Indiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
STEVEN NEUCKS MD

Rheumatology

9,266

$1.16M

803
365 are 65+

40%
patients receiving schedule two controlled substances

Avg: 5%

31%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 20%

$125
Average prescription price

Avg: $126

TIMOTHY LENARDO M.D.

Rheumatology

8,697

$1.25M

624
398 are 65+

13%
patients receiving schedule two controlled substances

Avg: 5%

22%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 20%

$143
Average prescription price

Avg: $126

WILLIAM RUSCHE M.D.

Rheumatology

7,484

$1.08M

421
202 are 65+

35%
patients receiving schedule two controlled substances

Avg: 5%

40%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 20%

$144
Average prescription price

Avg: $126

VINAY REDDY MD

Rheumatology

7,345

$1.1M

615
329 are 65+

13%
patients receiving schedule two controlled substances

Avg: 5%

28%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 20%

$149
Average prescription price

Avg: $126

THOMAS WORSTER MD

Rheumatology

7,096

$1.13M

341
183 are 65+

18%
patients receiving schedule two controlled substances

Avg: 5%

42%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 20%

$159
Average prescription price

Avg: $126

BRUCE LOCKWITZ M.D.

Rheumatology

6,583

$426K

711
587 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

21%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 20%

$65
Average prescription price

Avg: $126

LARRY GREENBAUM MD

Rheumatology

5,821

$867K

417
307 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

20%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 20%

$149
Average prescription price

Avg: $126

ALAN BIRNBAUM MD

Rheumatology

5,650

$591K

527
409 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 16%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 20%

$105
Average prescription price

Avg: $126

LARRY BRAZLEY MD

Rheumatology

5,464

$758K

299
204 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

30%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 20%

$139
Average prescription price

Avg: $126

HENRY DAVIS MD

Rheumatology

5,413

$613K

619
352 are 65+

19%
patients receiving schedule two controlled substances

Avg: 5%

35%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 20%

$113
Average prescription price

Avg: $126

MICHAEL LOCKWOOD MD

Rheumatology

5,357

$274K

440
328 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 16%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 20%

$51
Average prescription price

Avg: $126

NARCISA GERMAN M.D.

Rheumatology

5,346

$677K

391
259 are 65+

13%
patients receiving schedule two controlled substances

Avg: 5%

33%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 20%

$127
Average prescription price

Avg: $126

KAREN KOVALOW-ST. JOHN M.D.

Rheumatology

5,213

$660K

443
336 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

23%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 20%

$127
Average prescription price

Avg: $126

STEVEN KO M.D.

Rheumatology

4,950

$733K

433
321 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 20%

$148
Average prescription price

Avg: $126

GORDON HUGHES MD

Rheumatology

4,534

$498K

362
232 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

31%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 20%

$110
Average prescription price

Avg: $126

MOHSEN EHSAN M.D.

Rheumatology

4,490

$528K

597
394 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

5%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 20%

$118
Average prescription price

Avg: $126

ROSEMARIE JEFFERY MD

Rheumatology

4,458

$616K

345
244 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

20%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 20%

$138
Average prescription price

Avg: $126

RICHARD BELL MD

Rheumatology

4,316

$552K

364
251 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

24%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 20%

$128
Average prescription price

Avg: $126

JAMES EHLICH MD

Rheumatology

4,297

$528K

381
234 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 20%

$123
Average prescription price

Avg: $126

MOGES SISAY MD

Rheumatology

4,248

$605K

361
225 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 20%

$142
Average prescription price

Avg: $126

MICHAEL STACK MD PHD

Rheumatology

4,026

$492K

454
387 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 20%

$122
Average prescription price

Avg: $126

DOUGLAS SMITH M.D.

Rheumatology

3,966

$468K

449
377 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

23%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 20%

$118
Average prescription price

Avg: $126

DAVID BATT MD

Rheumatology

3,946

$673K

318
214 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

31%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 20%

$171
Average prescription price

Avg: $126

ARTUR KALUTA MD

Rheumatology

3,836

$393K

396
300 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

21%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 20%

$103
Average prescription price

Avg: $126

NICHOLAS STRANIERO M.D.

Rheumatology

3,795

$433K

414
303 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

17%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 20%

$114
Average prescription price

Avg: $126

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank